Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Digital Turbine (APPS) shares surged over 20% in pre-market trading after reporting better-than-expected quarterly results. Other notable pre-market movers include Expion360 (XPON), Anew Medical (WENA), Luxurban Hotels (LUXH), Coeptis Therapeutics (COEP), Aspen Aerogels (ASPN), Sezzle (SEZL), Color Star Technology (ADD), Fluence Energy (FLNC), and Staffing 360 Solutions (STAF) among gainers. Losers include Cardlytics (CDLX), Outset Medical (OM), Bumble (BMBL), Viracta Therapeutics (VIRX), Greenlane Holdings (GNLN), JFrog (FROG), Know Labs (KNW), Dutch Bros (BROS), Fastly (FSLY), and Precigen (PGEN).
August 08, 2024 | 10:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Color Star Technology shares gained 17.3% in pre-market trading after a 39% surge the previous day.
The continued price increase suggests sustained positive sentiment among investors.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 60
POSITIVE IMPACT
Digital Turbine shares rose sharply by 20.8% in pre-market trading after reporting better-than-expected quarterly financial results, with revenue and adjusted EPS beating consensus estimates.
The significant pre-market price increase is directly tied to the company's better-than-expected financial performance, indicating strong investor confidence.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Aspen Aerogels shares gained 21% in pre-market trading after reporting better-than-expected second-quarter revenue results.
The positive financial results have likely boosted investor confidence, leading to a significant pre-market price increase.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
Coeptis Therapeutics shares jumped 24.8% in pre-market trading.
The significant price increase indicates strong investor interest, though specific catalysts are not mentioned.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Fluence Energy shares gained 13.7% in pre-market trading after reporting better-than-expected third-quarter revenue results.
The positive financial results have likely boosted investor confidence, leading to a pre-market price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Luxurban Hotels shares gained 26.3% in pre-market trading after a previous decline of 11%.
The price increase suggests a recovery from the previous day's decline, possibly driven by bargain hunting or positive sentiment.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 60
POSITIVE IMPACT
Sezzle shares gained 18% in pre-market trading after reporting better-than-expected quarterly financial results.
The better-than-expected financial performance has likely driven the pre-market price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Staffing 360 Solutions shares rose 11.4% in pre-market trading after declining 8% the previous day.
The price increase suggests a recovery from the previous day's decline, possibly driven by bargain hunting or positive sentiment.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Anew Medical shares gained 25% in pre-market trading after announcing the grant and issuance of a patent for novel genetic approaches for neurodegenerative diseases.
The patent announcement is a positive development, likely boosting investor confidence in the company's future prospects.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 70
POSITIVE IMPACT
Expion360 shares rose 36.5% in pre-market trading after a sharp decline the previous day due to a $10 million underwritten public offering.
The rebound in share price suggests a recovery from the previous day's decline, likely driven by investor reassessment of the public offering's impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Bumble shares declined 39.8% in pre-market trading after reporting worse-than-expected second-quarter revenue results.
The significant price drop is directly tied to the company's poor financial performance, indicating strong negative sentiment among investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Dutch Bros shares fell 20.7% in pre-market trading after reporting second-quarter results.
The price drop suggests investor disappointment with the company's financial performance.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 70
NEGATIVE IMPACT
Cardlytics shares dipped 49.6% in pre-market trading after reporting worse-than-expected second-quarter financial results.
The significant price drop is directly tied to the company's poor financial performance, indicating strong negative sentiment among investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 90
NEGATIVE IMPACT
JFrog shares fell 27.4% in pre-market trading after reporting worse-than-expected second-quarter revenue results and issuing FY24 guidance below estimates.
The poor financial results and weak guidance have likely led to a significant drop in investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Fastly shares fell 20.5% in pre-market trading after issuing FY24 and Q3 guidance below estimates.
The weak guidance has likely led to a significant drop in investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Greenlane Holdings shares fell 36.1% in pre-market trading after a 58% jump the previous day.
The price drop suggests a correction following the previous day's significant increase.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 60
NEGATIVE IMPACT
Know Labs shares fell 21.5% in pre-market trading after pricing a $3.445 million public offering.
The price drop is likely due to dilution concerns following the public offering.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 70
NEGATIVE IMPACT
Outset Medical shares declined 47.1% in pre-market trading after reporting worse-than-expected second-quarter financial results and cutting FY24 revenue guidance.
The poor financial results and reduced revenue guidance have likely led to a significant drop in investor confidence.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 90
NEGATIVE IMPACT
Precigen shares fell 18.1% in pre-market trading after pricing a $30 million public offering.
The price drop is likely due to dilution concerns following the public offering.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 70
NEGATIVE IMPACT
Viracta Therapeutics shares declined 38.9% in pre-market trading.
The significant price drop indicates strong negative sentiment among investors, though specific catalysts are not mentioned.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 50